6 Recruiting Idiopathic Pulmonary Fibrosis (IPF) Phase 2 Clinical Trials
Active phase 2 studies for idiopathic pulmonary fibrosis (ipf) enrolling across the USA. Verify eligibility and contact site coordinators.
All Idiopathic Pulmonary Fibrosis (IPF) studiesPhase 2 Studies for Idiopathic Pulmonary Fibrosis (IPF)
🔵 Active, Not Recruiting Phase2
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
📍 UAB Hospital, School of Medicine/Lung Health Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
📍 National Jewish Health — Denver, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
📍 Royal Prince Alfred Hospital — Camperdown, New South Wales
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
📍 UAB Lung Health Center — Birmingham, Alabama
View Study & Checklist ➔